---

$0.90

-0.1000 ( -10.10% ) 29.1K

Celularity Inc is a clinical-stage biotechnology company developing off-the-shelf placental-derived allogeneic cell therapies including genetically modified and unmodified NK cells, engineered T cells including CAR-T cells, and mesenchymal-like adherent stromal cells, targeting indications across cancer, immunologic, infectious, and degenerative diseases. It manages its operations through an evaluation of three distinct business segments which include Cell Therapy, Degenerative Disease, and bio-banking. The company generates the majority of its revenue from bio-banking segment.

Type: All Buy Sale Start date: End date: Filter Reset

Date	Type	Amount Purchased	Purchaser
2024-02-21	Sale	-43968.00	Beers David C
2024-02-21	Sale	-32720.00	Brigido Stephen
2024-02-21	Sale	-39571.00	Fletcher Kyle
2024-01-17	Buy	21410983.00	Lim Kok Thay
2023-10-16	Sale	-1250000.00	Ling Geoffrey M.D.
2023-10-10	Buy	9064539.00	Hariri Robert J
2023-10-05	Sale	-9064539.00	Sorrento Therapeutics, Inc.